Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

2309 ARTÍCULOS , VIENDO DEL 1426 AL 1440

Hippocampal subfield volumes in mild cognitive impairment and alzheimer's disease: a systematic review and meta-analysis

Zhang J, Xie L, Cheng C, Liu Y, Zhang X, Wang H, Hu J, Yu H, Xu J.

Brain Imaging Behav. 2023 Dec;17(6):778-793. doi: 10.1007/s11682-023-00804-3. Epub 2023 Sep 28.

Physical activity and exercise for the prevention and management of mild cognitive impairment and dementia: a collaborative international guideline

Veronese N, Soysal P, Demurtas J, Solmi M, Bruyère O, Christodoulou N, Ramalho R, Fusar-Poli P, Lappas AS, Pinto D, Frederiksen KS, Corbi GM, Karpenko O, Georges J, Durães J, Schlögl M, Yilmaz O, Sieber C, Shenkin SD, Smith L, Reginster JY, Maggi S, Limongi F, Ars J, Barbagallo M, Cherubini A, Quinn T; Alzheimer Europe; European College of Neuropsychopharmacology; European Geriatric Medicine Society (Lead Society); European Interdisciplinary Council on Ageing; European Society of Clinical and Economic Aspects of Osteoporosis and Osteoarthritis; International Association of Gerontology and Geriatrics-European Region; Scottish Brain Health ARC; World Psychiatry Association-Preventive Psychiatry Section; endorsed by the European Academy of Neurology.

Eur Geriatr Med. 2023 Oct;14(5):925-952. doi: 10.1007/s41999-023-00858-y. Epub 2023 Sep 28.

Combined exercise and cognitive interventions for adults with mild cognitive impairment and dementia: A systematic review and network meta-analysis

Xue D, Li PWC, Yu DSF, Lin RSY.

Int J Nurs Stud. 2023 Nov;147:104592. doi: 10.1016/j.ijnurstu.2023.104592. Epub 2023 Sep 1.

Air pollution, glymphatic impairment, and Alzheimer's disease

Hussain R, Graham U, Elder A, Nedergaard M.

Trends Neurosci. 2023 Nov;46(11):901-911. doi: 10.1016/j.tins.2023.08.010. Epub 2023 Sep 28.

Repetitive Behaviors in Alzheimer's Disease: A Systematic Review and Meta-Analysis

Polin C, Gellé T, Auditeau E, Adou C, Clément JP, Calvet B.

J Alzheimers Dis. 2023;96(2):483-497. doi: 10.3233/JAD-230380.

A Mediterranean Diet and Walking Intervention to Reduce Cognitive Decline and Dementia Risk in Independently Living Older Australians: The MedWalk Randomized Controlled Trial Experimental Protocol, Including COVID-19 Related Modifications and Baseline Characteristics

Pipingas A, Murphy KJ, Davis CR, Itsiopoulos C, Kingsley M, Scholey A, Macpherson H, Segal L, Breckon J, Minihane AM, Meyer D, Ogden E, Dyer KA, Eversteyn E, Hardman RJ, Poorun K, Justice K, Hana M, Buckley JD, White D, Davison K, Clark JS, Bracci EL, Kennedy G; MedWalk collaborative team.

J Alzheimers Dis. 2023;96(1):409-427. doi: 10.3233/JAD-230641.

Diagnostic performance of MRI radiomics for classification of Alzheimer's disease, mild cognitive impairment, and normal subjects: a systematic review and meta-analysis

Shahidi R, Baradaran M, Asgarzadeh A, Bagherieh S, Tajabadi Z, Farhadi A, Korani SS, Khalafi M, Shobeiri P, Sadeghsalehi H, Shafieioun A, Yazdanifar MA, Singhal A, Sotoudeh H.

Aging Clin Exp Res. 2023 Nov;35(11):2333-2348. doi: 10.1007/s40520-023-02565-x. Epub 2023 Oct 6.

The therapeutic landscape of tauopathies: challenges and prospects

Cummings JL, Gonzalez MI, Pritchard MC, May PC, Toledo-Sherman LM, Harris GA.

Alzheimers Res Ther. 2023 Oct 6;15(1):168. doi: 10.1186/s13195-023-01321-7.

Precision Medicine Approach to Alzheimer's Disease: Rationale and Implications

Bredesen DE, Toups K, Hathaway A, Gordon D, Chung H, Raji C, Boyd A, Hill BD, Hausman-Cohen S, Attarha M, Chwa WJ, Kurakin A, Jarrett M.

J Alzheimers Dis. 2023;96(2):429-437. doi: 10.3233/JAD-230467.

Rapamycin Responds to Alzheimer's Disease: A Potential Translational Therapy

Hou SJ, Zhang SX, Li Y, Xu SY.

Clin Interv Aging. 2023 Oct 2;18:1629-1639. doi: 10.2147/CIA.S429440. eCollection 2023.

Etiology of Alzheimer's Disease

Zhang C.

Discov Med. 2023 Oct;35(178):757-776. doi: 10.24976/Discov.Med.202335178.71.

Amyloid Positron Emission Tomography and Subsequent Health Care Use Among Medicare Beneficiaries With Mild Cognitive Impairment or Dementia

Rabinovici GD, Carrillo MC, Apgar C, Gareen IF, Gutman R, Hanna L, Hillner BE, March A, Romanoff J, Siegel BA, Smith K, Song Y, Weber C, Whitmer RA, Gatsonis C.

JAMA Neurol. 2023 Nov 1;80(11):1166-1173. doi: 10.1001/jamaneurol.2023.3490.

Tau trajectory in Alzheimer's disease: Evidence from the connectome-based computational models

Bitra VR, Challa SR, Adiukwu PC, Rapaka D.

Brain Res Bull. 2023 Oct 15;203:110777. doi: 10.1016/j.brainresbull.2023.110777. Epub 2023 Oct 7.

South Asian, Black and White ethnicity and the effect of potentially modifiable risk factors for dementia: A study in English electronic health records

Mukadam N, Marston L, Lewis G, Mathur R, Lowther E, Rait G, Livingston G.

PLoS One. 2023 Oct 11;18(10):e0289893. doi: 10.1371/journal.pone.0289893. eCollection 2023.

Neuropsychological impairment in amyotrophic lateral sclerosis-frontotemporal spectrum disorder

Abrahams S.

Nat Rev Neurol. 2023 Nov;19(11):655-667. doi: 10.1038/s41582-023-00878-z. Epub 2023 Oct 12.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias